Language
Grade: Pharmaceutical Grade
Factory Location: China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 500kg
Contract Manufacturing: CRO,CMO
Packaging Information: 5kg/drum
Delivery Lead Time: 15days
Sample Provided: yes
Payment Terms: T/T
Sunitinib is indicated for the following conditions:
- Treatment of adult patients with gastrointestinal stromal tumor (GIST) following disease progression on (or intolerance to) imatinib mesylate
- Treatment of adult patients with advanced renal cell carcinoma (RCC)
- Adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy
- Treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease
